Ameriprise
VRTX icon

Ameriprise’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$971M Sell
2,181,362
-54,107
-2% -$24.1M 0.24% 87
2025
Q1
$1.08B Buy
2,235,469
+219,946
+11% +$107M 0.29% 67
2024
Q4
$812M Buy
2,015,523
+143,713
+8% +$57.9M 0.21% 99
2024
Q3
$871M Sell
1,871,810
-182,971
-9% -$85.1M 0.22% 93
2024
Q2
$963M Sell
2,054,781
-170,526
-8% -$79.9M 0.26% 78
2024
Q1
$930M Sell
2,225,307
-284,722
-11% -$119M 0.26% 82
2023
Q4
$1.02B Sell
2,510,029
-427,783
-15% -$174M 0.31% 65
2023
Q3
$1.02B Sell
2,937,812
-86,031
-3% -$29.9M 0.34% 59
2023
Q2
$1.06B Sell
3,023,843
-366,017
-11% -$129M 0.33% 62
2023
Q1
$1.07B Sell
3,389,860
-188,787
-5% -$59.5M 0.35% 57
2022
Q4
$1.03B Sell
3,578,647
-463,346
-11% -$134M 0.35% 60
2022
Q3
$1.17B Sell
4,041,993
-520,956
-11% -$151M 0.43% 41
2022
Q2
$1.29B Sell
4,562,949
-384,414
-8% -$108M 0.45% 40
2022
Q1
$1.29B Buy
4,947,363
+524,167
+12% +$137M 0.38% 50
2021
Q4
$969M Buy
4,423,196
+1,034,106
+31% +$227M 0.27% 74
2021
Q3
$615M Buy
3,389,090
+650,315
+24% +$118M 0.2% 111
2021
Q2
$552M Buy
2,738,775
+820,708
+43% +$165M 0.17% 129
2021
Q1
$412M Buy
1,918,067
+1,100,467
+135% +$236M 0.14% 161
2020
Q4
$193M Sell
817,600
-22,268
-3% -$5.26M 0.07% 296
2020
Q3
$228M Sell
839,868
-444,227
-35% -$121M 0.09% 231
2020
Q2
$373M Sell
1,284,095
-888,799
-41% -$258M 0.16% 136
2020
Q1
$517M Sell
2,172,894
-236,171
-10% -$56.2M 0.27% 73
2019
Q4
$527M Buy
2,409,065
+30,299
+1% +$6.63M 0.22% 91
2019
Q3
$403M Sell
2,378,766
-62,955
-3% -$10.7M 0.18% 114
2019
Q2
$448M Buy
2,441,721
+78,258
+3% +$14.4M 0.2% 103
2019
Q1
$435M Sell
2,363,463
-1,986,539
-46% -$365M 0.2% 100
2018
Q4
$721M Sell
4,350,002
-1,393,382
-24% -$231M 0.36% 51
2018
Q3
$1.11B Sell
5,743,384
-82,081
-1% -$15.8M 0.39% 49
2018
Q2
$988M Buy
5,825,465
+220,446
+4% +$37.4M 0.44% 39
2018
Q1
$914M Buy
5,605,019
+349,639
+7% +$57M 0.41% 42
2017
Q4
$787M Sell
5,255,380
-176,700
-3% -$26.5M 0.36% 56
2017
Q3
$826M Sell
5,432,080
-973,672
-15% -$148M 0.39% 49
2017
Q2
$826M Sell
6,405,752
-1,832,449
-22% -$236M 0.41% 42
2017
Q1
$901M Sell
8,238,201
-468,434
-5% -$51.2M 0.47% 35
2016
Q4
$641M Buy
8,706,635
+11,204
+0.1% +$825K 0.35% 53
2016
Q3
$758M Sell
8,695,431
-328,644
-4% -$28.7M 0.42% 43
2016
Q2
$776M Sell
9,024,075
-379,072
-4% -$32.6M 0.45% 43
2016
Q1
$747M Sell
9,403,147
-187,047
-2% -$14.9M 0.45% 44
2015
Q4
$1.21B Sell
9,590,194
-571,203
-6% -$71.9M 0.71% 26
2015
Q3
$1.06B Buy
10,161,397
+286,836
+3% +$29.9M 0.66% 26
2015
Q2
$1.22B Sell
9,874,561
-81,333
-0.8% -$10M 0.69% 19
2015
Q1
$1.17B Buy
9,955,894
+642,075
+7% +$75.7M 0.67% 23
2014
Q4
$1.11B Sell
9,313,819
-184,044
-2% -$21.9M 0.64% 22
2014
Q3
$1.07B Buy
9,497,863
+2,419,288
+34% +$272M 0.64% 21
2014
Q2
$670M Sell
7,078,575
-1,047,185
-13% -$99.1M 0.4% 46
2014
Q1
$575M Buy
8,125,760
+334,295
+4% +$23.6M 0.35% 63
2013
Q4
$579M Buy
7,791,465
+1,833,313
+31% +$136M 0.35% 59
2013
Q3
$452M Buy
5,958,152
+1,375,662
+30% +$104M 0.3% 65
2013
Q2
$366M Buy
+4,582,490
New +$366M 0.25% 81